Biblio
Trailblazing perspectives on targeting breast cancer stem cells. Pharmacol Ther. 2021:107800.
. Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML). PLoS One. 2015;10(4):e0122983.